20.81
BATS BZX Real-Time Price
As of 2:44pm ET
 -0.28 / -1.33%
Today’s Change
18.03
Today|||52-Week Range
32.50
-31.55%
Year-to-Date
Calithera's Kidney Cancer Candidate Gets Fast Track Status
Apr 19 / Zacks.com - Paid Partner Content
Moving Average Crossover Alert: Exelixis, Inc. (EXEL)
Apr 06 / Zacks.com - Paid Partner Content
Exelixis (EXEL) in Focus: Stock Moves 7.7% Higher
Apr 11 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close21.09
Today’s open21.30
Day’s range20.76 - 21.40
Volume100,038
Average volume (3 months)3,021,474
Market cap$7.3B
Data as of 2:44pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+24.44%
Earnings growth (next 5 years)+40.38%
Revenue growth (last year)+136.44%
P/E ratio42.5
Price/Sales20.95
Price/Book25.50

Competitors

 Today’s
change
Today’s
% change
ICLRICON PLC-0.76-0.64%
CRLCharles River Labora...-0.09-0.08%
PRAHPRA Health Sciences ...-0.02-0.02%
----
Data as of 2:28pm ET, 04/20/2018

Financials

Next reporting dateMay 3, 2018
EPS forecast (this quarter)$0.13
Annual revenue (last year)$452.7M
Annual profit (last year)$153.9M
Net profit margin33.99%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael M. Morrissey
Chief Financial &
Accounting Officer, Executive VP
Christopher J. Senner
Corporate headquarters
South San Francisco, California

Forecasts